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ABSTRACT
EFFECT OF QUANTUM DOTS, NOVEL BIOLOGICAL
IMAGING AGENTS, IN LIVER CELLS
IN VITRO
by
Utshaha Maharjan
May 2016
The use of Quantum dots (QDs) coated with polymer and functionalized with
carboxylic acid groups in medical applications are explored. Their water solubility and
exceptional stability in aqueous environments make them potentially useful for such
applications as imaging and ligand attachments. However, there are concerns regarding
the toxic effects of QDs and the minimal dose that can be used without producing any
detrimental effects to organisms. In this study, QDs coated with the amphiphilic polymer
coating tri-n-octylphosphine oxide and poly (maleic anhydride-alt-1-tetradecene (TOPOPMAT)) which is functionalized with carboxylic acid groups were used to investigate
their toxic effect in mouse liver cells. The cells were treated with 2 nM, 20 nM and 40
nM of QDs for a 24 -hour period and assays were performed to determine the effect on
cell viability, ATP production, mitochondrial membrane potential and reactive oxygen
iii

species (ROS) production. The results showed no significant effect on cell viability, ATP
production and ROS production. However, the mitochondrial membrane potential of cells
was significantly decreased when treated with 20 nM and 40 nM QDs. The results
suggest that TOPO-PMAT QDs could be mildly toxic and precaution should be taken if
used in higher concentration than 20 nM.
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CHAPTER I
INTRODUCTION
Nanoparticles and Their Uses
Nanoscience is the study and application of extremely small materials that can
range from 1-100 nm in size.1 The use of nanotechnology in medicine is spreading
rapidly as a lot of biological events take place in nanoscale; for example, a strand of
DNA is only about 2 nm in diameter, and hemoglobin, an oxygen carrying protein, is 5.5
nm in diameter. Engineered nanoparticles are explored for their possible use in drug
delivery and cancer imaging and therapy. Due to their small size (1-100 nm) and
relatively large functional surface area, these particles are able to bind, adsorb and carry
other compounds such as drugs, antibodies and chemical fluorescence probes, and deliver
them to targets in the body.2 The main reason to use these nanoparticles in drug delivery
is to decrease the side effects and toxicity of drugs used in the treatments.2 Although
these nanoparticles can be very useful for different purposes in medicine, there have been
concerns that these nanoparticles could be toxic to the human biological system and may
have detrimental effects on human body parts ranging from cell function to organ
function such as lungs, brain and heart.2
Quantum Dots
There are several nanoparticles available such as nanotubes, nanowires, fullerenes
and quantum dots (QDs). Among several nanoparticles, we are interested in QDs as they
are fully described in terms of their chemical compositions and can be used for various
medical applications.3 QDs used in this study are highly stable in aqueous environments.4
1

Due to their high stability in aqueous environments they are very useful for biological
imaging and the carboxyl functional group in the coating makes it convenient for ligand
attachment for use in targeting specific cancers or cells.5 There are various uses of QDs in
photovoltaic cells, drug delivery, cancer imaging and as different biochemical probes.
Similarly, further research has shown their promising use for in vivo applications by
directing antibodies to cancer cell surface receptors and for siRNA delivery.6
The Chemical Composition of Quantum Dots
The chemical composition of QDs can be customized according to their uses.
They usually consist of three parts: a core, a shell and a coating. There are several
different types of cores, shells and coatings that can be customized according to the
application. QDs have an inorganic semi-conductor core that determines their optical
properties. The core of QDs are mostly composed of elements from groups III and V,
such as InAs or GaN or groups IIB & VI, such as CdSe, CdS, CdTe, ZnSe, ZnS or ZnTe.
The QDs whose cores are composed of elements from groups IIB and VI such as CdSe
and CdS of periodic table emit visible light and are developed for biomedical purposes
like diagnosis and cancer therapy. The shells in QDs are commonly composed of ZnSe,
ZnS or CdS. Similarly, the QDs can be coated with various compounds depending upon
their application, such as SiO2, polymers and other molecules such as TOPO (tri-noctylphosphine oxide). Also, they are often attached to biomolecules such as RNA, DNA,
protein and lipids that are used to label cells or tissues, enter inside cells or deliver drugs
to specific organs in the body. The physical properties of QDs such as solubility, charge,
efficiency of optical emission and toxicity can be affected by its coating.7
2

In this study we are using TOPO-PMAT QDs provided by our collaborators at the
University of Washington. The TOPO-PMAT QDs are made up of a CdSe core, a ZnS
shell which are surrounded by a TOPO (tri-n-octylphosphine oxide), and a PMAT (poly
(maleic anhydride-alt-1-tetradecene)) polymer coating (Figure 1). The intermolecular
force that holds TOPO and PMAT are hydrophobic interactions. The hydrophobic
interaction between TOPO and PMAT makes it very stable in aqueous solution which
makes it very useful for medical purposes. The absorbance spectrum of these TOPOPMAT QDs was determined to be between 400 nm to 500 nm and the fluorescence
spectrum showed the maximum fluorescence emission at 620 nm (Figure 2).8

Figure 1: Diagram of TOPO-PMAT Quantum Dots.8
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Figure 2: Maximum absorbance and emission of TOPO-PMAT Quantum Dots.8

Applications of Quantum Dots
TOPO-PMAT quantum dots are useful for biological imaging because of their
high water solubility due to the carboxylic group attached to the outside and exceptional
stability. These QDs can be used for molecular markers in cells instead of organic dyes
and antibodies. Mortalin, a member of hsp 70 protein family which is a marker of
transformed and normal cells depending upon its staining pattern can be stained easily
with fluorescing quantum dots which otherwise requires several steps of staining with
primary and secondary antibodies.9 Kaul and colleagues showed that the mortalin
staining pattern was uniform in cytoplasm and the perinuclear (space between the inner
and outer layer of nucleus) in transformed (osteocarcinoma, U2OS) cells as reported
previously by using the organic fluorescent dyes.9 In addition, staining with QDs also
provides longer fluorescence time. Mortalin stained with the organic dye “Alexa probe”
4

fades away after 3 minutes whereas the mortalin stained with QDs remained for 8
minutes giving longer and more accurate visualization.
Similarly, the presence of carboxyl functional groups in the coating of these QDs
make them useful for ligand attachment. These kind of QDs can be modified accordingly
for tumor targeting in vivo using antibodies directed to ligand surface receptors on cancer
cells. Yang and colleagues coupled antibody (ScFvEGFR) with QDs to deliver the
epidermal growth factor receptor (EGFR) in epidermal growth factor (EGF) expressing
tumor in vivo mice models via tail vein. The result showed that there were large amounts
of QDs bound to tumor cells in sections taken from frozen tumor tissues.10 This shows
that the QDs can be modified to target the tumor cells. Likewise, QDs can also be used
for SiRNA delivery. SiRNA can be used in knocking down any type of mRNA which can
be very useful in genomic studies and treatment of some tough diseases such as cancer.
However, the delivery of siRNA in vivo is very difficult in practice which can be solved
using QDs as a delivery vehicle. At least 50 copies of SiRNA were delivered to the
targeted site by using TOPO-QDs in rats with xenograft prostrate tumors.11 There are
many probable applications of quantum dots in medical fields, and research is ongoing on
the use of QDs in medical applications. However, there are concerns regarding the toxic
effect of QDs when used for medical purposes.

Potential Toxic Effect of Quantum Dots
Despite their usefulness, concerns have been raised about QDs’ potential toxic
effects in organisms. There are several types of quantum dots depending on their uses.
5

They can be customized according to their uses and applications. They can differ in their
structure, coating, size, diameter, surface charge, exposure time and the environment they
are used in. These differences in manufacturing and use determine their stability which in
turn determine the toxic effect of QDs in living organisms. Stable QDs are more resistant
to photo-oxidation and remain intact for longer periods of time. Photo-oxidation is most
likely to occur in unstable QDs and release the components of their cores, shells and
coating resulting in cadmium related cytotoxicity to cells.12 Unmodified “Naked" QD
cores are known to produce reactive oxygen species which could be detrimental to
organisms.6 The induced reactive oxygen species could result in damage to biological
membranes including plasma membranes and mitochondrial membranes.7
Due to multiple compositions and uses of QDs, their negative effect on biological
systems is under intense study especially the toxicity of coating materials. Several QDs
can be customized in terms of its shell and coating depending on their use, so it is very
necessary to investigate the toxic effect on organisms. The proper surface coatings can
reduce their toxic effect on organisms. Kim and colleagues investigated the effect of two
differently coated QDs, one with 3 mercaptopropionic acid and another with tri-noctylphosphine oxide (TOPO) in Daphnia magna. The experiment showed that the
TOPO coated QDs caused a decrease in survival rate of Daphnia magna when treated
with higher concentrations (100 µg/L) and 3 mercaptopropionic acid coated QDs
treatment did not show any changes in survival rate across all the treatment
concentrations.12 One study showed that the CdSe QDs treated neuroblastoma cells
6

caused cell death via a cadmium-induced mitochondrial apoptosis pathway due to
formation of reactive oxygen species. 13
In another study, toxicity of QDs coated with polyethylene glycol (PEG) in
different conditions were tested in zebrafish.14 Zebrafish were treated with both
oxidatively degraded and non-degraded PEG-coated QDs for 48 hours. The result showed
that both degraded and non-degraded QDs had increased effect in death of zebrafish.
However, the degraded QDs produced a severe effect when tested for morphological
deformities such as pericardial, ocular and yolk sac edema. The weathered or oxidatively
degraded QDs produced more pronounced morphological disorder even in lower
concentrations (20 µM). The quantum dots coated with organic-COOH showed decreased
cell viability at the lower concentration of 20 nM when treated up to 24 hours while the
QDs coated with PEG showed reduced cell viability at 80 nM treated up to 48 hours in
murine macrophages cells.15 There are several studies for determining the cytotoxic effect
of QDs on cells but the doses used varies from one study to another. Similarly, studies
have shown that QDs with amphiphilic or protein coatings or ZnSe or ZnS shell are less
cytotoxic.16
Similarly, the size of QDs affects their distribution and retention time in vivo.
QDs’ coating diameter determine the fate of their accumulation or excretion. QDs are
excreted via urine if the hydrodynamic diameter is less than 5.5 nm. If the diameter is
bigger than 5.5 nm, there is a chance that these QDs are deposited in liver.17 Also, the
same study determined that the increasing hydrodynamic diameter increases blood half7

life. Another study reported that the smaller sized QDs accumulated in liver within 1 hour
of treatment and later accumulated in liver (15-80 days exposure) and the large QDs
accumulated in spleen.18 Similar studies done with PEG chains of different length which
resulted in different hydrodynamic radii, showed that the increase in PEG length
increased the retention time of QDs in liver.19
Surface charge of the QDs also plays an important role in determining the toxicity
of QDs. Some research has shown that negatively charged QDs are less toxic than
positively charged QDs. Some biological applications of QDs requires the use of
positively charged QDs such as in the SiRNA delivery process.11 Quantum dots with
negatively charged coatings PEG-COOH or positively charge coating PEG-NH2 caused
severe coagulation and pulmonary thrombosis at the highest dose.20 Another study done
using similar (PEG-COOH and PEG- NH2) QDs showed that the cytotoxic effect starts to
appear when treated with doses of 20 nM after 24 hours of exposure.21 A similar study
showed that coating of QDs determines the subcellular localization of QDs. PEG-NH2
coated QDs were localized in lysosomes and mitochondria while the non-functionalized
PEG coated QDs were distributed evenly throughout the cells.15
In addition to the structures of coating, the stability of QDs also depend upon the
environment of their use. Decreased growth rate was observed in Gram-positive Bacillus
subtilis and Gram-negative Escherichia coli when treated with QDs dissolved in
solutions weathered in different pH values. The toxic effect was due to the degradation
and release of their coating, shell and core materials.22 Kim et. al., (2010) exposed QDs
8

coated with TOPO and 3 mercaptopropionic acid to different forms of light such as white
fluorescence light with or without UV-B for two days. The Daphnia magna exposed to
TOPO-QDs exposed to UV-B for 2 days showed a significant rise in production of
reactive oxygen species (ROS). In another experiment, the ability of QDs to withstand
the intracellular conditions was determined by treating kidney epithelial cells with QDs.
The result showed that the structure of QDs were not intact and leaked the cadmium out
of its core. The acidic and oxidative environment of the lysosome could be responsible
for the breakdown of QDs. Studies have shown that hypochlorous acid and hydrogen
peroxide degrade the QDs’ polymer coating, resulting in the release of core
components.22
Toxicity can also be affected by the exposure time. In vivo studies have shown
that the QDs can remain in mice up to two years and in some tissues up to 4 years inside
a body of an organism. When these are accumulated in vivo these also show the blue shift
in fluorescence. The blue shift is due to the loss of cadmium and selenium ions from QDs
which imply that the QDs used are being degraded.23
Mechanism Behind Negative Effect
The mechanism of the negative effect of QDs on cells is not fully understood but
the evidence has shown that cadmium binds and deactivates thiol (sulfhydryl) groups on
iron-sulfur proteins that are essential for proper cellular and mitochondrial function.24
One way to monitor the effects of QDs on living organisms is studying their effect on the
subcellular organelle, the mitochondrion, as it is considered the powerhouse of cells due
9

to its capability of producing energy in the form of ATP which is required for proper
functioning of cells.
Mitochondria
Most eukaryotic cells consist of these subcellular organelles, mitochondria that
are approximately 10 μm in size. The number of mitochondria present in cells depends
upon their metabolic capabilities. They consist of two membranes, outer and inner
membranes, with an intermembrane space in between (Figure 3). The outer membrane is
permeable and the inner membrane is highly selective compared to the outer membrane
and only allows some substances to pass depending on the transport system. The inner
membrane surface area is large due to numerous foldings called cristae. Inside the inner
membrane is a compartment filled with different enzymes known as the matrix. The
double membrane structure plays an important role in ATP synthesis and in apoptotic
signaling pathways. In the inner membrane, the mitochondrial electron transport chain is
located and ATP synthesis occurs by the process of oxidative phosphorylation.
Mitochondria are also responsible for the metabolism of fats and proteins and the
removal of toxic ammonia via the urea cycle and for signaling apoptosis or programmed
cell death. The proper functioning of mitochondria is necessary for healthy and active
cells and tissues. Studies have shown that mitochondrial dysfunction may be tied to
various metabolic and degenerative diseases such as Parkinson’s, atherosclerosis, cancer,
cardiovascular disease, type II diabetes and dementia.25

10

Figure 3: A mitochondrion showing inner membrane, outer membrane, intermembrane
space, matrix and cristae. 26

ATP Synthesis
The majority of ATP required for proper functioning of cells is produced by the
process of oxidative phosphorylation which includes functions of the electron transport
chain and F0F1 ATP synthase located in mitochondria. The inner membrane of
mitochondria consists of four enzyme complexes which are coupled with the enzyme
complex necessary for ATP synthesis, the F0F1 ATP synthase by a proton motive force.
The four complexes, complex I (NADH: ubiquinone oxidoreductase), complex II
(Succinate: ubiquinone oxidoreductase), complex III (Ubiquinone: cytochrome c
oxidoreductase) and complex IV (cytochrome c oxidase) use several oxidation-reduction
reactions to harvest electrons from the substrates nicotinamide adenine dinucleotide
(NADH) and succinate. The harvested electrons are used to reduce the final electron
acceptor molecular oxygen to water and create a proton gradient. Electrons flow from
complex I and II (lower reduction potential) to complex III and IV (higher reduction
11

potential). The energy produced from oxidizing substrates is used in pumping protons
across the inner membrane to the intermembrane space, which results in a proton gradient
and an electrochemical potential across the inner mitochondrial membrane known as the
mitochondrial membrane potential.25 In the electron transport chain, the electron from
complex I or II (NADH or succinate) is transferred to the oxidized form of coenzyme Q
or ubiquinone resulting, in reduction of coenzyme Q. The reduced form of coenzyme Q is
called ubquinol, which migrates towards complex III. During this process, complex I is
able to pump protons towards the intermembrance space. At complex III, ubquinol is
oxidized again, one electron at a time, and the electrons within the membrane are
transferred to cytochrome c. From cytochrome c, the electrons are transported to complex
IV. In complex IV, electrons are transferred to molecular oxygen, generating 2 moles of
water per mole of oxygen. In addition, complex IV also drives protons across the
membrane creating a proton gradient. The proton gradient is used by F0F1 ATP synthase
to produce ATP from ADP and phosphate ions. During ATP synthesis, the created proton
motive force activates the catalyst to drive the reaction between ADP and phosphate ions
to produce ATP. In this way, active healthy mitochondria are able to use oxygen, form
water, and maintain the ATP levels in cells through oxydative phosphorylation (Figure
4). However, during this process, reactive oxygen species are produced as a by-product of
the reaction.

12

Figure 4: Electron transport chain and F0F1 ATPase showing oxidative phosphorylation
and ROS production.27

ROS Production
The mitochondrial electron transport plays an important role in producing ATP
which is very essential for life. However, during the process a small amount of electrons
leak and react with oxygen which results in the formation of reactive oxygen species
(ROS). The first ROS produced by mitochondria is superoxide anion radical. In the
electron transport chain (ETC) oxygen is reduced to water through a four electron
reduction on the surface of complex IV. However, some oxygen is converted to
superoxide by a one-electron reaction with ubisemiquinone. This is converted into more
stable hydrogen peroxide (H2O2) due to the action of Mn-superoxide dismutase (SOD)
present in the matrix of mitochondria. The converted H2O2 can be removed by the
13

antioxidant system comprised of catalase and glutathione peroxidase. In addition, H2O2
produced in mitochondria also acts as a signaling molecule in the cytosol affecting
multiple networks such as cell cycle and stress response. If there is an excessive amount
of H2O2 production due to excessive stress on cells, the antioxidant system of cells may
not work efficiently to remove it. As a result, H2O2 may generate hydroxyl radical (OH·),
which is very reactive and is responsible for damaging any molecule it comes into contact
with.25 Hence the measure of H2O2 produced in cells can be used as a tool for measuring
the oxidative stress caused by ROS.
Since mitochondria are very important organelles for the well-being of cells and
are responsible for the generation of power for proper functioning of cells, studying the
effects of QDs on this organelle is an effective way to monitor the toxicity of QDs in
living organisms. The well-being of cells results in proper functioning of tissues and
proper functioning of tissues results in proper functioning of organs, which in turn results
in the well-being of an organism. Previous studies in the Thomas lab have shown that the
mitochondrial functions are negatively affected after treating cells with QDs for 24
hours.27 In this experiment, we are treating mouse liver cells with three different
concentrations of QDs for 24 hours and monitoring their effects on the proper functioning
of cells.

14

Liver Cells as Models for Quantum Dots Toxicity Studies
Biodistribution in vivo studies in Sprague-Dawley rats showed that QDs are
initially targeted to liver and spleen.28 The core metal of QDs, Cd was present in 0.92 µg
Cd g-1 after 24 hours of injection and 1.69 µg Cd g-1 after 30 days of injection.28 Since
liver is the major target organ for QDs, liver cell culture models for the safety assessment
of QDs would be relevant and applicable. The biological model used should be able to
produce a reliable prediction when eventually used in in vivo systems. The measurement
of toxicity in in vitro cultured liver cells would be comparable to the effect of quantum
dots in liver. The liver is one organ which breaks down and metabolizes the toxins from
all parts of the body and excretes them as harmless by-products into the bile, the intestine
and feces. When using quantum dots for biological imaging or any other medical
purposes, QDs will probably be routed to the liver. Thus the cytotoxicity assays done in
mouse liver cells would be an excellent model to predict the effect of QDs in liver.

15

CHAPTER II
METHODS AND MATERIALS
In this experiment, Hepa-V cells lines were obtained and maintained in the
laboratory. A total of four assays were conducted in this study. In the first two assays,
cell viability assay and ATP luminescence assay, cells were plated in a 96 well plate, and
in another two assays, mitochondrial membrane potential assay and reactive oxygen
species (ROS) assay, cells were plated in a 24 well plate. The number of cells plated were
5000 cells/100 μL for 96 well plate assay and 105 cells/mL for 24 well plate assay. The
details of the procedures are listed below.

Cell Culture and Passage
The Hepa-V hepatocyte cell line was obtained from collaborators at the
University of Washington. The media for cell growth was prepared by adding 50 mL of
Nu-serum and 10 mL of 100 U/mL streptomycin in 500 mL of Dulbecco’s Modified
Eagle Medium (DMEM)/F12 medium. The cells were grown in the prepared growth
medium at 37 °C in a 95% air and 5% CO2 humidified atmosphere in a 25 cm2 tissue
culture flask. The cell line was maintained by passing cells once or twice a week. For the
passing of cells, the older media was removed and cells were washed with 3 mL of
phosphate buffered saline (PBS) at pH 7.4. After washing, cells were treated with 1.5 mL
of 0.05% trypsin dissolved in PBS for two minutes at 37°C in a 95% air and 5% CO2
humidified atmosphere. The treatment of cells with trypsin detached cells from the
bottom of the flask. After cells were detached from the bottom 5 mL of media was added
16

to stop the activity of trypsin. The mixture of media and trypsin was then transferred to a
sterile conical tube and centrifuged at 800 rpm for 6 minutes. The trypsin and media
mixture was aspirated and the pellet of cells in the bottom of a conical tube was resuspended in 5 mL fresh media. 1 mL of resuspended cells in fresh media was taken and
transferred to a sterile flask and 4 mL of fresh media was added. The new flask was
incubated at 37 °C in a 95% air and 5% CO2 humidified atmosphere. This process of
transferring cells from one flask to the other is known as passage of cells. Cells from
passage 1 through 9 were used in this study.8, 29
From the remaining resuspended cells in 5 mL of fresh media, 100 μL of the cell
suspension was removed and diluted with 200 μL of water, then 10 μL of that solution
was added to a hemocytometer and the number of viable cells was counted under the
inverted microscope.

Counting Cells using a Hemocytometer and Plating Cells for Experiments
A hemocytometer microscope slide has etching or markings that consists of four
large clear squares on the corners divided into 16 smaller squares each. The detail on the
hemocytometer can be seen in figure 5. After 10 μL of diluted cell sample was applied to
the hemocytometer, a coverslip was placed on the cells. Cells in each of those four
squares including one large central square in the middle were counted. The average
number of viable cells counted under an inverted microscope on these five large squares
were calculated by dividing the total number of cells counted by 5. The total number of
cells present in each mL of media was determined by using the following formula:
17

average number of cells counted in 5 squares of the hemocytometer X dilution factor X
104. After the number of cells per mL was determined, the cells were diluted using cell
growth media to 5000 cells/ 100 μL for a 96 well plate assay and 105 cells/ mL for a 24
well plate assay.

Figure 5: Glass hemocytometer diagram showing square spaces used in counting cells.
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Treatment of Cells with Quantum Dots
TOPO-PMAT QDs were also provided by our collaborators at the University of
Washington. QDs were stored in microfuge tubes wrapped in parafilm at room
temperature inside a black conical tube to protect them from light. Cells were cultured in
96 or 24 well plates for 24 hours, and then treated with three different concentrations of
QDs (2, 20 and 40 nM) for 24 hours at 37 °C and 5% carbon dioxide.8 The stock solution
of 900 nM of QDs in PBS was sterilized with a 0.22 μm filter attached to a sterile
syringe. The sterilized QDs in PBS were diluted using an appropriate volume of DMEM
medium with 10 % Nu-serum and 100 U/mL streptomycin. For 96 well plate assays, 100
μL of final volume was maintained and for 24 well plate assays the final volume of 400
μL was maintained for all three concentration of treatments. Following the 24-hour QDs
treatment, the four assays were conducted.

Cell Viability Assay
The cell viability assay was used to determine the ability of cells to maintain or
recover viability. It is an enzyme-based method that works by determining the
mitochondrial dehydrogenase activity in the living cells. In this experiment we used a
water-soluble tetrazolium salt, [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4disulfophenyl)-2H-tetrazolium, monosodium salt] (WST-8, Dojindo Inc.), which is a
modified MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, to
monitor the mitochondrial dehydrogenase activity of cells. WST-8 salts receive two
electrons from viable cell mitochondrial dehydrogenases to generate an orange, yellow or
19

purple formazan crystal. The assay was used to monitor the effect of QDs on cell
proliferation compared to untreated cells. In this assay, 5000 cells per 100 μL were plated
and grown for two days or until cells were 80% confluent and treated with three different
concentrations of QDs. On the day of assay, older media and QD treatment was aspirated
and replaced with 90 μL of fresh media and 10 μL of WST-8 salt. One well was added
with 90 μL of 40 nM QDs only and 10 μL of WST-8 salt which gave the background
absorbance of QDs only. Then the cells were incubated for 4 hours at 37 °C and 5%
carbon dioxide. After incubating for 4 hours, the contents of each well was transferred to
unused wells and absorbance was read at 450 nm using a Synergy II plate reader. The
background absorbance reading of QDs was subtracted from the absorbance value of
QDs treated wells. The negative control used in this experiment was 20% dimethyl
sulfoxide (DMSO). The working mechanism of WST-8 in determining cell viability can
be seen in following reaction (Figure 6),
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Figure 6: WST-8 reduction reaction in presence and absence of dehydrogenase. WST-8 is
reduced by the dehydrogenase activity of cells into WST-8 formazan which is absorbed
at 450 nm. Dehydrogenase is only produced by healthy cells and is proportional to the
number of healthy cells. In absence or low amount of dehydrogenase, lower amount of
WST-8 is converted to WST-8 formazan and absorbance at 450 nm decreases.

Adenosine Triphosphate (ATP) Luminescence Assay
Cells consume energy during their regular cellular processes of growth and
metabolism. The required cellular energy form for these processes is adenosine
triphosphate (ATP). When cells are treated with QDs, the amount of ATP produced by
cells may be affected. The ATP luminescence assay was used to determine the amount of
ATP in QD-treated cells compared to control cells. Cells were plated and treated
similarly to the cell viability assay except a 96 well white luminescence plate was used.
After the 24 hour QD treatment in 96 well plates, cells were washed with PBS buffer and
treated with 35 μL of 1.5% triton X-100 at room temperature for 20 minutes. The
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treatment of cells with Triton-X 100 solubilized the cell membranes to release
cytoplasmic ATP. Then, 100 μL of assay solution (250 mM glycylglycin buffer, pH of
7.3, 2 mM EGTA, 2 mM MgCl2˙6H2O, 7.5 mM dithiothreitol, 15 μM luciferin and 10 μg/
mL luciferase) was added to the each well and the luminescence intensity of the reaction
was measured immediately using a Synergy II luminescent plate reader with a plugged
hole in the excitation filter wheel and a hole in the emission filter wheel. The ATP
produced by cells in each well with the treatment of QDs was compared to the ATP
produced by control cells and recorded as percent of control.30 The amount of ATP
produced in control cells was determined by the ATP standard curve with concentrations
ranging from 10 -6 to 10 -9 nM by monitoring luminescence with a Synergy II plate reader.
For positive control (lower amount of ATP production), cells were treated with 10 μM
antimycin A for 6 hours and luminescence was quantified. 1 μL of 1 mM of Antimycin A
stock solution prepared in 1:1 PBS and ethanol was taken and added to positive control
wells resulting in final concentration 10 μM of antimycin A and 0.5% of ethanol in each
positive control well. The reaction of ATP with luciferin in the presence of luciferase is
shown in Figure 7.
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+ Light

Figure 7: Reaction of luciferin and ATP in presence of luciferase.

Flow Cytometry
A flow cytometer (Bio-Rad S3e cell sorter) was used to collect data for two
assays: the mitochondrial membrane potential assay and the reactive oxygen species
(ROS) assay. Both of the assays used fluorescent dyes. The dye, JC- 10 was used for
mitochondrial membrane potential assay. JC-10 dye exists as monomers in the cytoplasm
and monomers aggregate to form J-aggregates inside the mitochondria in cells which was
measured in two different excitation/ emission spectra in the flow cytometer. The filter 1
(FL1) channel measures the fluorochrome emission between 525 ± 30 nm and the filter 2
(FL2) channel measures fluorochrome emission between 586 ± 25 nm. In this case, the
JC-10 dye is the fluorochrome. The JC-10 dye was examined for median fluorescence
intensities using both of these channels and a fluorescence intensity ratio (FL2/FL1) was
calculated. For the ROS assay only the median fluorescence intensity at FL1 was
measured. Each experiment was performed until 50,000 events were collected. The
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number of events refers to the number of single cells analyzed in the experiment. The
collected number of events were analyzed by using a software program called FlowJo
(V.10.1). FlowJo allows users to choose a population of cells to be analyzed, a process
known as “Gating”. It is a process by which dead cells and debris that have been counted
as events in the experiment are separated from the actual population of live cells being
analyzed.
Mitochondrial Membrane Potential Assay
The mitochondrial membrane potential is related to the cell’s ability to make
ATP. To monitor the effect of QDs on mitochondrial membrane potential, a lipophilic
cationic dye JC-10 (Enzo Life Sciences) was used and analyzed using a flow cytometer in
the Biology Department at CWU. Cells were plated in 24 well plates at 1 X 10 5 cells per
mL and incubated until cells were 85 % confluent. After treating cells with QDs for 24
hours, QDs and media were aspirated and cells were washed with 200 μL of warm PBS.
6.7 μL of 1.5 mM JC-10 dye dissolved in 1:1 dimethyl sulfoxide (DMSO) and 20 mM 4(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer in Hank’s Balanced
Salt Solution (HBSS) with final pH of 7.3 with 0.02% pluronic F-127 and 493.3 μL of
media was added to each well making the final concentration of dye to be 20 μM. The
final concentration of DMSO in cells was maintained to be 0.67%. After the treatment of
cells with JC-10, cells were incubated for 30 minutes at 37 °C in a 95% air and 5% CO2
humidified atmosphere.31 After the incubation, cells were washed with warm PBS and
200 μL of 0.05% trypsin was added. Cells were detached from the culture flasks and 500
μL of media was added to stop the activity of trypsin. Cells were transferred to a 5 mL
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microfuge tube and centrifuged for 6 minutes at 800 rpm. Then the media and trypsin mix
was aspirated and cells were re-suspended in HHBS buffer. Then the cell samples were
analyzed using flow cytometry. QDs exposed cells treated with JC-10 produces green
emission (JC-10 monomers) and orange emission (JC-10 aggregates) indicating low and
high mitochondrial membrane potential, respectively. Fluorescence intensities from
channels FL1 and FL2 were measured in cells by flow cytometry, the median
fluorescence intensity was analyzed and determined using FlowJo. The ratio of
fluorescence intensities at FL2/FL1 was calculated. For a positive control, cells were
treated with 5 μM of carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP) in
ethanol for 10 minutes and then treated with JC-10 dye.32 The 5 μM of FCCP was
prepared from the stock solution of 1 mM FCCP dissolved in ethanol. 5 mL of the stock
solution was added to 495 μL of media resulting in final concentration of 5 μM FCCP
and 1.1% of ethanol.

Growing Cells for Fluorescence Microscopy
For the fluorescence microscopy experiment Hepa-V cells were grown on a cover
slip. The 22 mm square coverslip was sterilized by spraying with 70 % ethanol and then
with flame. The coverslip was placed in a 60 X 15 mm petri dish. 1 mL of cells
resuspendend in 4 mL of DMEM/F12 was added to the petri dish. The cells were allowed
to grow for 48 hours in 37 °C in a 95% air and 5% CO2 humidified atmosphere. After 48
hours, media from the petri dish was removed and added with 3.0 mM JC-10 dye
dissolved in 1:1 DMSO and 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
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(HEPES) buffer in Hank’s Balanced Salt Solution (HBSS) with final pH of 7.3 with
0.02% pluronic F-127 and DMEM/F12. Then the petri dish was incubated for 1 hour.
Then, the petri dish contents were aspirated and the coverslip was washed with 5 mL of
PBS twice. After washing, the coverslip was taken out of the petri dish using tweezers
and placed inverted on a microscope glass slide. The coverslip was placed on the glass
slide in such a way that the side on which cells were growing faced the glass slide. Two
drops of PBS were added to the glass slide before placing the coverslip. Excess PBS after
placing the coverslip was removed using a Kim wipe. After placing the coverslip in the
desired position, it was sealed using clear nail polish on all 4 sides of the coverslip. After
the nail polish dried, the whole slide was cleaned with lens cleaner and read under a
fluorescence microscope and images were taken.33

Intracellular ROS Assay
The intracellular reactive oxygen species (ROS) production was measured using a
fluorescent dye called CellRox green (Invitrogen, Inc.) and flow cytometry. Cells were
plated at 100,000 cells / mL in 24 well plate and incubated until 85% confluent then cells
were treated with QDs for 24 hours. On the day of the assay, the plated cells were
aspirated and 498 μL of fresh media was added. 2 μL of 250 μM of CellRox green dye
was then added to the cell plated wells and incubated for 45 minutes protected from the
light giving a final concentration of CellRox green of 1 μM. After the incubation, the
media was removed and cells were removed from the plate with trypsin and resuspended
in FACS (fluorescence activated cell sorting) buffer which consists of 1% BSA and 0.1%
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sodium azide buffer. For a positive control, 498 μL of 300 μM tert-butyl hydroperoxide
(TBHP) diluted in media was added to the cells and incubated for 45 minutes.34 TBHP
reacts with ferrous iron to produce hydroxyl radical via a process of Fenton chemistry
where the iron is oxidized by the TBHP (Figure 8).

Figure 8: TBHP reaction with ferrous ion to produce hydroxyl radical, •OH.

Statistics
For each experiment, the data collected was averaged and standard deviation (Cell
viability and ATP assay) or range (Mitochondrial membrane potential and ROS assay)
were calculated. Data collected for each experiment was analyzed for statistical
significance by using one-way ANOVA and the significance was set to P ≤ 0.05. All the
statistical analyses were done by using Microsoft Excel version 2013. The replicates for
the experiments were 3 to 6.
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CHAPTER III
RESULTS
Cell Viability
A cell viability assay was used to determine the effect of QDs on cell proliferation
and the cytotoxic effects to cells that would eventually lead to cell death. Cell viability
was evaluated by using a modified water soluble MTT assay. In this method, water
soluble tetrazolium salt is reduced due to the activity of mitochondrial dehydrogenases.
The measurement of activity of mitochondrial dehydrogenase produced by the active and
healthy cells helps to determine the cell viability. Hepa-V cells showed a trend of
decreased mitochondrial dehydrogenase activity when treated with 2 nM, 20 nM and 40
nM QDs. The trend showed that the cells treated with 2 nM, 20 nM and 40 nM QDs
appear to have 21.5%, 20.9% and 13.8% decreased cell viability respectively (Figure 9).
However, the decrease in dehydrogenase activity was not statistically significant (P>0.05)
compared to control cells analyzed by one-way ANOVA. The positive control used in
this experiment (20% DMSO) showed 73% decrease in cell viability. DMSO at
concentrations higher than 10% causes cells to undergo apoptosis.35
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Figure 9: Cell viability in liver cells after 24-hr exposure to QDs. Liver cell
mitochondrial dehydrogenase activity measured by the water soluble MTT assay (WST8). Analysis by one-way ANOVA (p=0.08, n=6), indicates no significant effect of QDs
on metabolic cell death. Positive control cells were treated with 20 % DMSO for 1 hr.

ATP Content in Cells
Adenosine 5'- triphosphate (ATP) is very crucial in biological systems for
exchanging energy. It is produced and present in all metabolically active cells as an
immediate free energy donor. The production of ATP in cells denotes the cellular
integrity as cells require ATP for proper functioning. An ATP luminescence assay was
used to determine the quantity of ATP produced by Hepa-V cells. In this method, the
substrate luciferin was used which reacts with ATP in the presence of the enzyme
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luciferase to produce light. The result showed that there was no significant decrease in
ATP produced by cells when treated with different concentrations of QDs (p>0.05, oneway ANOVA). There was a trend of 2%, 2% and 14% decrease in ATP production by
cells when treated with 2 nM, 20 nM and 40 nM QDs, respectively (Figure 10). However,
it was not statistically significant.
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Figure 10: ATP production in liver cells after 24-hr exposure to QDs. ATP production of
liver cells was determined by the Luciferase/luciferin luminescence assay. Control
consists 1.5% Triton-X 100. Positive control cells were treated with 10 µM Antimycin A
for 6 hours. Analysis by one-way ANOVA (P= 0.17, n=6) indicates no significant effect
of QDs on ATP production of cells. ATP values of the control cells ranged between 42
nM and 88 nM per 5000 cells.

The positive control used in this experiment was 10 µM antimycin A which
showed 98% decrease in ATP production. Antimycin A is an antibiotic which interferes
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with electron flow from complex III to cytochrome C. In the presence of antimycin A
cytochrome c remains oxidized, eventually stopping the process of ATP production.

Mitochondrial Membrane Potential Assay using JC-10
Mitochondria are considered to be the power house of cells since they generate
ATP. The change in mitochondrial membrane potential (Δψm) indicates the capacity of
mitochondria to generate ATP and maintain cell health. In this experiment, a cationic
lipophilic dye (JC-10) was used in order to determine Δψm in cells. JC-10 is a
mitochondrial membrane permeable dye which can exist in its monomeric and Jaggregate forms depending on the Δψm. As mitochondria become more polarized
(increase Δψm), more JC-10 enters mitochondria and JC-10 starts forming J- aggregates
shifting the fluorescence emission from 530 nm to 590 nm, fluorescing red. In healthy
cells, the amount of J- aggregate is always equal to or higher than that of the monomer.
The result from fluorescence microscopy showed that the JC-10 dye used for the
mitochondrial membrane potential assay appears to fluoresce both green (FL1) and red
(FL2) uniformly in the cytoplasm of healthy cells (Figure 11).
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Panel A

Panel B

Figure 11: Fluorescence microscopy images of localization of JC-10 dye in Hepa-V cells.
Cells were grown on a coverslip for 48 hours and treated with JC-10 dye for 45 minutes.
Separate images were taken using different fluorescence filters for cells (panel A: ex/em:
488/530 nm and Panel B: ex/em: 488/590 nm)

As the mitochondrial membrane potential decreases, the amount of fluorescence at FL2
decreases and hence the ratio of FL2/ FL1.
A Δψm assay was performed using JC-10 dye and cells were analyzed using flow
cytometry. The JC-10 dye forms J- aggregates which fluoresces with emission at 590 nm
(FL2). In healthy cells with a high mitochondrial membrane potential, the accumulation
of J- aggregates is equal to or higher than its monomeric form. The results showed that
the ratio of FL2/ FL1 decreased as the concentration of QDs increased. The ratio of FL2/
FL1 is similar when compared between the control cells and cells treated with 2 nM QDs.
The fluorescence intensity FL2/ FL1 ratio of cells treated with 20 nM and 40 nM
significantly decreased compared to control cells (P < 0.05, one-way ANOVA) (Figure
12).
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Figure 12: Mitochondrial membrane potential in liver cells after 24-hr exposure to QDs.
JC-10 dye (20 µM) was added to Hepa-V liver cells and incubated for 30 min. Postive
control cells were treated with FCCP (5 µM) and incubated for 10 min. The median
fluorescence intensities for both J-aggregates and monomeric forms of JC-10 were
measured, at Ex/Em = 488/590 nm and 488/525 nm with flow cytometry and their ratio
was calculated (FL2/FL1). Analysis by one-Way ANOVA (P= 0.00017, n=2) indicates
significant effect of QDs on Δψm. Two values were averaged and the error bar represents
the range of those values.

The decrease in FL2/ FL1 ratio showed that the amount of J- aggregates
accumulated in mitochondria of cells decreased as the concentration of QDs increased in
the cells. The decrease in amount of J- aggregates suggested that the mitochondrial
membrane potential of cells was decreasing with increased concentration of QDs in cells.
The positive control (FCCP) showed a decrease in mitochondrial membrane potential
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denoted by decreased FL2/ FL1 ratio. FCCP uncouples the mitochondria as a result of
which mitochondrial membrane potential decreases.32
Reactive Oxygen Species (ROS) Production in Cells
Cells produce reactive oxygen species (ROS) during the process of formation of
ATP through oxidative phosphorylation. In normal conditions, cells have their own
antioxidant mechanism to remove ROS. However, under stress cells may be making more
ROS than they remove. The presence of ROS in cells is an indicator of stress due to
exposure to chemicals such as QDs. In this experiment the ROS produced by cells when
treated with QDs were measured by the fluorescence intensity of CellRox green dye
which fluoresces brightly in the presence of reactive oxygen species and is detected using
the FL1 filter in the flow cytometer. Due to limited amount of QDs, the experiment was
performed two times only. The data for these experiments is questionable because the
flow cytometer was clogged on the day of the experiment and cells were stored in
refrigerator for more than two hours before analyzing in flow cytometer. We were unable
to combine these two experiments together and do a statistical analysis on it.
The first experiment (trial 1) showed the decreased trend in production of ROS
when treated with QDs compared to control cells. It showed that the production of ROS
in cells treated with 20 nM and 40 nM had a decreased trend as compared to control cells
but increased trend as compared to cells treated with 2 nM QDs. However, the positive
control in the experiment also showed a decrease in ROS production. For the positive
control, cells were treated with tertiary butyl hydrogen peroxide (TBHP), a known ROS
producer with an expected result of increasing ROS (Figure 13, Panel A).
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The second experiment (trial 2) showed similar trends. The production of ROS
showed a decreased trend in cells treated with QDs as compared to control cells. The
production of ROS in cells treated with 20 nM appeared to decrease as compared to
control cells but appeared to increase as compared to the cells treated with 2 nM and 40
nM QDs. The positive control also showed an increase in ROS production which was
expected (Figure 13, Panel B).
Even though the positive control did not work on the first experiment, the results
are comparable in both the experiments. The trend of decreased ROS when treated with 2
nM QDs was similar in both experiments. When treated with 20 nM, QDs production
ROS decreased as compared to control but increased as compared to 2 nM treatment and
the trend is similar in both experiments. When treated with 40 nM QDs, the ROS
production decreased as compared to control in both experiments. However, the ROS
production with 40 nM QDs treatment was equal to ROS production when treated with
20 nM QDs in first experiment, whereas it decreased slightly in second experiment.
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Figure 13: Production of reactive oxygen species (ROS) in liver cells after 24-hr
exposure to QDs. CellRox green dye (1 µM) was added to Hepa-V liver cells and
incubated for 45 min. Positive control cells were treated with 300 µM tertiary butyl
hydrogen peroxide (TBHP) and incubated for 45 min. The median fluorescence
intensities for CellRox green dye was measured at Ex/Em = 488/530 nm with flow
cytometry (FL1 median fluorescence intensity). Panel A contains the data from Trial 1
and panel B contains the data from the Trial 2 of the experiment performed on the same
day.
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Comparison of Fluorescence of QDs and JC-10 Dye
The quantum dots used in these experiments have a maximum fluorescence
emission at 620 nm which is measured with the FL3 filter on the flow cytometer.8
However, the emission spectrum of QDs showed some overlap in emission at wavelength
590 ± 25 nm, which can be measured by using FL2 in the flow cytometer. The dye used
in these experiments fluoresced and were analyzed and detected through FL1 or FL2 in
flow cytometer. To show that the median fluorescence intensity of dyes used such as JC10 and fluorescence of QDs did not overlap with each other, Hepa-V cells were treated
with 20 nM of QDs and analyzed with flow cytometry using filters FL2 and FL3. The
median intensity recorded for QDs at FL2 was 277 and at FL3 was 10,337 (Figure 14,
Panel A left and right). We compared these median fluorescence intensities to the median
fluorescence intensities of the cells treated only with JC- 10 dye. The fluorescence
intensity for cells treated only with JC- 10 was 265 at FL2 (Figure 14, Panel B, and Left).
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Panel A

Panel B
Figure 14: Median fluorescence intensity of Quantum dots (Panel A) and JC-10 (Panel B)
in FL2 (left) and FL3 (Right). Hepa- V cells were treated with 20 nM QDs for 24 hours
and analyzed using flow cytometry. The median fluorescence intensity of QDs in both
FL2 (panel A, left) and FL3 (Panel A, right) is shown. The median fluorescence intensity
of JC-10 treated cells in both FL2 (panel B, left) and FL3 (panel B, right) is shown.

The median fluorescence intensity of QDs in cells is similar to that of control cells
with JC-10 stain only. Thus, the result showed that the background of QDs was not
responsible for the data collected in FL2. Also, the result showed that QD fluoresces
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remarkably higher when detected through FL3 more than 37-fold increment as compared
to FL2.
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CHAPTER IV
DISCUSSION
The TOPO-PMAT QDs used in this study are the group of QDs that would be
used in imaging and medical purposes due to their extraordinary properties. These QDs
are highly soluble and stable in aqueous environments.8 The carboxylic functional group
attached to the coating makes these QDs applicable for ligand attachment which would
be very helpful in medical applications.
The cells used in this study are mouse liver cells (Hepa-V) and represent the cells
of the organ which TOPO-PMAT may encounter if used for medical purposes. QDs with
a bigger diameter than 5.5 nm are most likely deposited in the liver.17 The diameter of
TOPO-PMAT QDs used in this experiment is 12.7±0.5 nm8, so these are most likely to
be deposited in liver. Also as the size increases, the retention time of QDs in liver
increases.19 Since the liver is the target organ for the QDs of this size, the experiment
performed in liver cells is representative of the effect that these QDs may have in liver
when used in vivo.
The analysis of cells using flow cytometry after treating with QDs for 24 hours
showed that the QDs were present inside the cells and that the majority of the QDs’
fluorescence was detected through channel (FL3) (Figure 14, panel A). The finding was
similar to previous work done in the Thomas research lab in Hepa-1c1c7 (CR-17) cells.27
Hepa-1c1c7 cells are also mouse liver cells but with enhanced glutathione levels. The
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result showed that Hepa-1c1c7 cells were able to uptake and internalize the QDs after 4
hours of treatment.27 Smith et al. (2012) showed that, nearly all HepG2 (human liver
cells) were able to internalize TOPO-PMAT QDs.36 Similar studies with different cells
(human macrophages, human kidney cells) confirmed that the QDs were internalized by
these cells.8 These data showed that TOPO-PMAT QDs can be readily internalized by
cells when the QDs come in contact with live cells. Hence a thorough study should be
undertaken before considering the use of these QDs in vivo as they can be readily
internalized by many different types of cells.
Our results showed that the QDs did not have any significant effect on cell
viability of Hepa-V cells. This result is similar to previous studies in human hepatocytes
cells. Human hepatocytes did not show any decrease in cell viability when treated with 2
nM to 40 nM TOPO-PMAT QDs over 24-48-hour period.36 Although our experiment did
not show any significant decrease in cell viability, the treatment of cells with 2 nM, 20
nM and 40 nM QDs showed a trend of decreased cell viability by 21.5%, 20.9% and
13.8% respectively. The cell viability decreased by 20% in lower concentration of
treatment while it decreased by only 13.8% at higher concentration treatment. The
finding is similar to the McConnachie and colleagues’ cell viability experiment
conducted in human kidney cells in which the percent of cell viability increased as the
concentration of TOPO-PMAT QDs increased to 40 nM.8 This can be attributed to the
activation of metabolic function of cells to make Nicotinamide adenine dinucleotide
phosphate (NAD(P)H) more available under stress that may have been produced due to
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exposure to QDs.37 The presence of more NAD(P)H allows cells to remove more ROS
using glutathione peroxidase for example, which converts hydrogen peroxide to water
and oxygen.
Similarly, our results showed that there was not a significant change in ATP
production when cells were treated with 2 nM, 20 nM and 40 nM of QDs. The ATP
production showed a decreased trend, by only 2% when treated with 2 nM and 20 nM
QDs, and by 14% when treated with 40 nM QDs. This trend showed that the amount of
ATP produced by cells was constant and cells were able to maintain the amount of ATP
produced. In previous studies it was shown that cells under stress are triggered to produce
more ATP.38 The level of intracellular ATP increases as a result of induced stress.38 The
release of ATP is a response of cells to induced stress. When cells were treated with
different concentrations of QDs, cells were exposed to the stress. It is possible that in
response to the QDs induced stress, cells started generating intracellular ATP. The
intracellular ATP can be generated from glycolysis and other metabolism pathways such
as the citric acid cycle in order to regulate the normal function of cells. When cells are
treated with 40 nM of QDs, the ATP production trend decreased compared to control and
other treatment cells. The stress from higher concentration treatment may have been more
than the cells could handle as a result of which the ATP concentration decreased as
compared to the other treatments.
The energy produced from oxidizing substrates in the electron transport chain is
used in pumping protons across the inner membrane to the intermembrane space, which
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results in a proton gradient and an electrochemical potential across the inner
mitochondrial membrane known as the mitochondrial membrane potential. The proton
motive force is used to generate ATP through ATP synthase. The measure of
mitochondrial membrane potential is a sign of healthy and functioning cells. The result
showed that the mitochondrial membrane potential decreased significantly when treated
with 20 nM and 40 nM of QDs. Interestingly, mitochondrial membrane potential
increases slightly when treated with 2 nM QDs. Similar studies on the effect of CdTe
QDs on mitochondria showed that the mitochondria swell in the presence of QDs. They
permeablize the mitochondrial inner membrane to H+ and K+ ions. These ions play an
important role in distribution of charges across the inner mitochondrial membrane. The
disturbance in this distribution of charges decreases the proton electrochemical gradient.
This effect increased as the concentration of QDs increases from 50 nM to 50 µM.39 The
appropriate level of ion concentration is very important for the proper functioning of the
mitochondria for the energy generation through the proton electrochemical potential
gradient. In the presence of QDs the balance of these appropriate ion gradients is
disturbed and the membrane potential decreases. The decrease in membrane potential
indicates mitochondrial uncoupling. Uncoupling of mitochondria disrupts the process of
ATP formation and ROS production.
A ROS assay was performed using CellRox green dye and the result showed that
the production of ROS decreases when treated with different concentrations of QDs in
two experiments. ROS are produced in cells as a by-product of ATP formation through
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oxidative phosphorylation. Cells have their own antioxidant process to remove these ROS
through reaction with superoxide dismutase and glutathione peroxidase. However, if cells
start producing more ROS, the cells’ natural antioxidant system may not be able to
remove ROS giving rise to the presence of ROS in cells putting cells under oxidative
stress. So the measurement of ROS when they are exposed to QDs is a way to determine
the oxidative stress cells are going through.
The trend in both the experiments showed that ROS production decreased when
treated with different concentration of QDs. Even though the flow cytometer was not
functioning and cells had to be stored in the refrigerator for more than two hours before
analysis, the trend of decreased ROS production in cells treated with QDs were similar in
both experiments (Figure 13). Similar effects had been shown when cells are treated with
uncoupling protein such as UCP 3 and UCP 1.39 The presence of these proteins plays a
role in uncoupling oxidative phosphorylation which reduces the mitochondrial membrane
potential. We observed a significant decrease in mitochondrial membrane potential in
cells treated with QDs. When mitochondria started depolarizing and the mitochondrial
membrane potential decreased in the presence of uncoupling protein UCP 3 an UCP 1,
the production of ROS was decreased which is in parallel to our findings. In addition, a
study on the effect of MPA-CdSe/ZnS QDs on plant cells (Sativa cells) showed that cells
responded to oxidative stress by increasing the antioxidant enzyme systems such as
superoxide dismutase.40 When cells are put under stress they respond to it by
upregulating antioxidant enzymes.41 It is possible that when cells were treated with QDs,
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cells were under stress and upregulated the antioxidant enzyme as a result of which ROS
production decreased.
However, other studies showed the increase in ROS in spite of an increase in
antioxidant enzyme. The study was performed on liver cells of Mus musculus mouse
(AML 12) treated with 20 µg/mL- 40 µg/mL CdTe QDs for 24 hours, which showed a
significant increase in ROS.42 The doses used in this experiment were very high
compared to our experiment. It is possible that at lower doses (2 nM – 40 nM), the
increased function of antioxidant systems is enough to remove the ROS and when the
concentration of QDs treatment increases it is difficult for cells to remove ROS in spite of
upregulation of antioxidant enzymes.
The QDs used in this study are composed of a CdSe/ZnS core/shell. Studies have
shown that CdSe/ZnS QDs treated MCF-7 cells showed the presence of cadmium to be
low to none when detected by Cd2+ cell assay compared to other QDs such as CdTe QDs.
Also it was found that CdSe/ZnS QDs were non-toxic in terms of cell viability. In
addition, the study showed that upon photoxidation CdTe QDs generate oxidative stress
which was not found in ZnS coated QDs.43 Since the CdSe core of the QDs used in our
studies were covered with ZnS, it is possible that we observed mild toxicity due to this
protective shell. The structure of QDs with ZnS may be manufactured in such a way that
they remain intact for a long period of time and with less leaking of the core component
cadmium which is associated with toxicity to cells.24
The internalization and toxic effects caused by QDs also depends upon the growth
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medium used in cell culture. Several nanoparticles such as QDs are known to form
coronas around them as the proteins in the growth media is absorbed by them. This may
mitigate the effects of QDs in cells.44 The type of protein coronas formed around QDs
depends upon the protein components added to the media. Studies have shown that the
use of fetal calf serum (FCS) in media may agglomerate the nanoparticles showing no or
low toxicity in cells.45 In our study all cells were grown in DMEM/F12 media
supplemented with 10% Nu-serum which is substituted for the FCS in the medium and
shows similar growth of cells. Nu-serum may have resulted in agglomeration of QDs
used in this experiment which may have resulted in no significant effect in cell viability.
However, a review paper on the formation of protein coronas states that the QDs with
amphiphilic coatings do not form large protein coronas compared to hydrophilic QDs.44
The QDs used in our study were amphiphilic QDs which may not have formed the
coronas and were not involved in mitigating the toxic effect of QDs. Hence, the observed
result may not be due to the formation of protein coronas around QDs. The QDs used
may be less toxic due to the presence of ZnS shell, TOPO-PMAT coating and carboxylic
acid functionalization. The shell and coating acted as a protective layer around the core of
QDs and prevented leaking of cadmium from the core.
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CHAPTER V
CONCLUSION
This study found that the TOPO-PMAT coated CdSe/ZnS QDs did not result in
significant decrease in cell viability and ATP production. In addition, the result showed
that these QDs resulted in a decrease in mitochondrial membrane potential which denotes
uncoupled mitochondria. Although the data may not be reliable due to instrument
malfunction, we observed a decrease in the production of reactive oxygen species (ROS).
These results on Hepa-V cells suggest that similar effects may be seen on liver cells if
used in vivo in humans.
These results showed that the use of TOPO- PMAT QDs is mildly toxic to cells
indicated by a trend towards decreasing cell viability, ATP production and a significant
decrease in mitochondrial membrane potential. At the lower concentration (2 nM), results
showed minimal effect on cell viability, ATP production and mitochondrial membrane
potential after a 24-hour treatment or exposure to QDs. This might indicate that it is safe
to use QDs at lower concentrations for in vivo medical applications. However, caution
should be applied if using in higher concentrations (20 nM or 40 nM) as the QDs may
have some detrimental effects in organisms.
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APPENDICES

APPENDIX A
Preliminary data using C60
Cell Viability

Cell viabilty assay using C60
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Figure A1. Cell viability after 24-hr exposure to C60. Liver cell mitochondrial
dehydrogenase activity measured by the water soluble MTT assay (WST-8). Analysis by
1-Way ANOVA (p<0.05, n=6), indicates a significant effect of C60 on metabolic cell
death. Negative control cells were treated with 20% DMSO for 1 hr.
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ATP Assay
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Figure A2: ATP production in liver cells after 24-hr exposure to C60. ATP production of
liver cells was determined by the Luciferase/luciferin luminescence assay. Vehicle
control consists of DMEM and the 7.5% BSA in PBS. Negative control cells were
treated with 10 M Antimycin A for 6 hours. (P> 0.05, n=9). ATP values of the control
cells ranged between 22 nM and 79 nM per 5000 cells.
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Figure A3. Mitochondrial membrane potential in liver cells after 24-hr exposure to C60.
JC-10 dye (20 µM) was added to Hepa-V liver cells and incubated for 30 min. Negative
control cells were treated with FCCP (5 µM) and incubated for 10 min. The median
fluorescence intensities for both J-aggregates and monomeric forms of JC-10 were
measured at Ex/Em = 488/590 nm and 488/525 nm with flow cytometry and their ratio
was calculated.
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APPENDIX B
STATSTICAL ANALYSIS (QDs Study)
Cell Viability
ANOVA
Source of
SS
Variation
Between
0.015184438
Groups
Within
0.037060867
Groups
Total
0.052245304

df

MS

F

P-value

F crit

3

0.005061479 2.594869305 0.082553804 3.127350005

19

0.001950572

22

ATP Assay
ANOVA
Source of
SS
Variation
Between
541.1337196
Groups
Within
1758.082964
Groups
Total
2299.216683

df

MS

F

P-value

F crit

3

180.3779065 1.846785609 0.174871735 3.15990759

18

97.67127576

21

Mitochondrial Membrane Potential Assay
ANOVA
Source of
Variation
Between
Groups
Within
Groups
Total

SS

df

MS

F

35.37440882

4

8.843602204 64.85889198 0.000169741 5.192167773

0.681757114

5

0.136351423

36.05616593

9
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P-value

F crit

APPENDIX C
FLOW CYTOMETRY DOT PLOTS and HISTOGRAMS FOR QDs
Mitochondrial Membrane Potential Assay
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Figure A4: Flow cytometry dot plots and histogram showing gating and median
fluorescence intensity at FL2 for mitochondrial membrane potential using JC-10 dye.
A (Top, Bottom): Gating and FL2 intensity of no stain cells, B (Top, Bottom): Gating and
FL2 intensity of stained cells, C (Top, Bottom): Gating and FL2 intensity of stained cells
treated with 2 nM QDs, D (Top, Bottom): Gating and FL2 intensity of stained cells
treated with 20 nM QDs, E(Top, Bottom):Gating and FL2 intensity of stained cells
treated with 240 nM QDs, F(Top, Bottom):Gating and FL2 intensity of stained cells
treated with 5 µM FCCP.
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Reactive oxygen species
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Figure A5: Flow cytometry dot plots and histogram showing gating and median
fluorescence intensity at FL1 for reactive oxygen species (ROS) assay using CellRox
green dye. A (Left, Right): Gating and FL1 median intensity of stained cells, B (Left,
Right): Gating and FL1 intensity of 2 nM, C (Left, Right): Gating and FL1 intensity of
stained cells treated with 20 nM QDs, D (Left, Right): Gating and FL1 intensity of
stained cells treated with 40 nM QDs, E (Left, Right): Gating and FL1 intensity of
stained cells treated with 10 µM of tert. butyl hydrogen peroxide.
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